Dual Implantable Port

Designed to provide long-term central venous access via a subcutaneously implanted port for repeated administration of fluids and medications and for blood sampling.

Key Features & Clinical Benefits

Designed in collaboration with cardiologists to solve the most common challenges in radial hemostasis.

Dual, independent lumens allow simultaneous infusion of medications that would otherwise be incompatible in a single line.

Vortex chamber technology helps cleanse the entire chamber and eliminate dead spaces in each lumen, reducing sludge build-up and the risk of occlusion.

Large septum diameter gives clinicians a greater target area for needle access, supporting confident, accurate cannulation on each attempt.

Product Overview

Designed to provide long-term central venous access via a subcutaneously implanted port for repeated administration of fluids and medications and for blood sampling.

Clinical Applications

Oncology

Palliative Care

Medical Wards

Haematology

Product Highlight

Vortex Dual Implantable Ports give clinicians dependable, repeated vascular access for patients who need two independent lines, such as simultaneous infusion of incompatible medications, or dedicated access for chemotherapy alongside parenteral nutrition or blood sampling, without the need for a second device. Featuring Vortex technology to reduce the need for secondary interventions.

Technical Assets

Need Support?

Connect with our product specialists for bulk orders and institutional inquiries.

Technical Specifications

Material
Dimensions
Classification
Weight
Kit Contents
Application Site
Quantity
Sterility
Recyclable
Carbon Footprint (CO2 Emissions)
Legal Manufacturer
Country of Origin
Shelf Life/Expiry
Handling
Dissolution Performance
Microbiological Safety
Customisation
Patient Suitability
Regulatory Status
Compatability
Formulation
Active Substance
Packaging
Lumens
Product contains Latex
Allergen Information
Radiation
Mode of Action
Life Cycle Duration
Dwell Time
Name of the Medical Product
Pharmaceutical Form
Purity
Strength
Product Type
Reconstituted Concentration
Administration Route
Imaging Technology
Excitation Wavelength/Maximum
Emission Wavelength/Maximum
Plasma Protein Binding
Distribution Profile
Metabolism
Elimination Pathway
Initial Plasma Half-Life
Radiation Exposure
Storage Conditions
Safety Profile
Device Type
Imaging Principle
Light Source
Image Resolution
Display
Working Distance
Focus Adjustment
Image/Video Format
Data Export
Internal Storage
Start-Up Time
Mobility
Albumin Rentention
Microglobulin Removal
Filtration Standards
Sterilisation Type
Technology